According to our new research study on “Human Microbiome Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Application, and Disease,” the market is expected to reach US$ 2,921.68 million by 2028 from US$ 718.95 million in 2021; it is estimated to grow at a CAGR of 22.2% during 2021–2028. The report highlights major market drivers and prominent companies along with their key developments in the market.
Technological advancements in metagenomics and next-generation sequencing have made microbiome-based testing easier and cheaper, and they have sped up the process of analysis of the genomic content of microorganisms from human sample. This has bolstered the development process for microbiome-based diagnostics. Gastrointestinal and metabolic disorders accounted for a large share of the diagnostics market in 2018 owing to high interest in developing an easy analysis platform for gut health-based disorders, such as irritable bowel syndrome and Crohn’s disease. Metabiomics is engaged in developing molecular diagnostics for detecting markers of colorectal cancer. Existing tests for colorectal cancer rely on invasive colonoscopies; and thus, the non-invasive test developed by Metabiomics that uses stool samples to evaluate patient’s gut microbiome would come up as a unique product meeting huge unmet needs.
DuPont and Yakult Honsha Co., Ltd – Notable Market Players in Human Microbiome Market
The human microbiota consists of the trillions of symbiotic microbial cells harbored by each person, mainly bacteria in the gut, the human microbiome consists of the genes these cells harbor. The microbes including bacteria, fungi and viruses are the disease-causing microbes that accumulate over time and changing their gene activity & metabolic processes and resulting in an abnormal immune response against the substances and tissues that normally present in the human body. Microbiome projects across the globe have been launched with the aim to understand the roles that these symbionts play and their impacts on human health.
Get Free Sample PDF – https://bit.ly/3TbIMi8
On the basis of geography, the human microbiome market is segmented into North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and South & Central America (SCAM). North America is projected to hold the largest market share in 2021, with the US being the leading shareholder, followed by Canada. The market growth in North America is credited to robust research activities in the human microbiome, increasing funding for biotechnology, rising health-consciousness among population, and surge in the demand for the probiotics and prebiotic to treat chronic diseases. Asia Pacific is expected register the highest CAGR in the human microbiome market during the forecast period. Countries such as China have an established market for human microbiome, whereas the demand in India and Japan is set to grow in the coming years owing the ongoing research and developments.
Market leaders operating in the market have undertaken various organic growth strategies in the human microbiome market. The human microbiome market majorly consists of the players such as MaaT Pharma, ELIGO BIOSCIENCE, AOBiome, Kaleido Biosciences, Inc., Seres Therapeutics, Merck & Co., Inc, Yakult Honsha Co., Ltd, Rebiotix, Inc., DuPont de Nemours, Inc, and Synthetic Biologics, Inc. amongst others. Some of the activities undertaken by the company, which have promoted its growth are, product launch, approvals, partnership and strategy and business planning. Companies such MaaT Pharma, AOBiome, Seres Therapeutics, Inc and others have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market.
Based on product, the human microbiome market is subsegmented into probiotics, foods, prebiotics, medical foods, diagnostic devices, drugs, and supplements. The human microbiome market, by disease, is segmented into diabetes, cancer, autoimmune disorders, obesity, mental disorders, and other diseases. Based on application, the market is segmented into diagnostics and therapeutics.
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information,
please contact us:
Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876
